Clinical Study

Use Of Molindone For The Treatment Of Impulsive Aggression In Children And Adolescents With Adhd

Posted Date: Jun 7, 2019

  • Investigator: Caleb Adler
  • Specialties: ADD/ADHD, Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Drug

This is an open label trial to evaluate the long term safety (up to 60 months) of a medication called Molindone in the treatment of Impulsive aggression in pediatric and adolescent subjects with ADHD when taken along with a standard ADHD medication.

Criteria:

The Subject Would Require To Be Diagnosed Historically With Adhd And Be On A Stable Dose Of A Fda Approved Adhd Medication Prior To Participating In The Study. Subjects With A History Of Mdd Or Any Psychotic Disorders Will Be Excluded. Subjects Are Enroll

Keywords:

Adhd, Add, Aggression

For More Information:

Dinesh Ganapathy
513-558-4413
ganapadh@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.